Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand
This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the complex relationship between tumor growth pattern and location, the high rate of postoperative recurrence, local invasiveness, use of nonsurgical therapy with molecularly targeted dr...
Saved in:
| Published in | Journal of Nippon Medical School Vol. 87; no. 4; pp. 184 - 190 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
The Medical Association of Nippon Medical School
15.08.2020
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1345-4676 1347-3409 1347-3409 |
| DOI | 10.1272/jnms.JNMS.2020_87-408 |
Cover
| Abstract | This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the complex relationship between tumor growth pattern and location, the high rate of postoperative recurrence, local invasiveness, use of nonsurgical therapy with molecularly targeted drugs, and best current treatments. This tumor has been referred to by various names, but is now most frequently referred to as TSGCT. TSGCT is classified as localized and diffuse, in accordance with its growth characteristics. Most TSGCTs of the fingers are localized. TSGCT is likely a neoplastic process arising from synovial lining cells, in which tumor cells express the colony stimulating factor 1 (CSF1) gene. The postoperative recurrence rate of TSGCT is approximately 15%. The intrinsic characteristics of recurrence are not clear, and complete resection of the lesion is still the treatment mainstay. Moreover, TSGCT commonly grows out of a pseudocapsule. Therefore, to perform complete resection of TSGCT, surgery must be performed cautiously after appropriate preparation, by using anesthesia, a tourniquet, surgical loupe, and surgical microscopy. After accurate preoperative diagnosis, meticulous planning by surgeons is necessary. The lesion should be resected along with approximately 1-mm of healthy tissue at the adhesion site. In addition, because satellite lesions might be present near the tumor, careful dissection and observation of the color of surrounding tissue are important. International clinical trials of CSF1 receptor inhibitors for TSGCT treatment are ongoing. |
|---|---|
| AbstractList | This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the complex relationship between tumor growth pattern and location, the high rate of postoperative recurrence, local invasiveness, use of nonsurgical therapy with molecularly targeted drugs, and best current treatments. This tumor has been referred to by various names, but is now most frequently referred to as TSGCT. TSGCT is classified as localized and diffuse, in accordance with its growth characteristics. Most TSGCTs of the fingers are localized. TSGCT is likely a neoplastic process arising from synovial lining cells, in which tumor cells express the colony stimulating factor 1 (CSF1) gene. The postoperative recurrence rate of TSGCT is approximately 15%. The intrinsic characteristics of recurrence are not clear, and complete resection of the lesion is still the treatment mainstay. Moreover, TSGCT commonly grows out of a pseudocapsule. Therefore, to perform complete resection of TSGCT, surgery must be performed cautiously after appropriate preparation, by using anesthesia, a tourniquet, surgical loupe, and surgical microscopy. After accurate preoperative diagnosis, meticulous planning by surgeons is necessary. The lesion should be resected along with approximately 1-mm of healthy tissue at the adhesion site. In addition, because satellite lesions might be present near the tumor, careful dissection and observation of the color of surrounding tissue are important. International clinical trials of CSF1 receptor inhibitors for TSGCT treatment are ongoing. This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the complex relationship between tumor growth pattern and location, the high rate of postoperative recurrence, local invasiveness, use of nonsurgical therapy with molecularly targeted drugs, and best current treatments. This tumor has been referred to by various names, but is now most frequently referred to as TSGCT. TSGCT is classified as localized and diffuse, in accordance with its growth characteristics. Most TSGCTs of the fingers are localized. TSGCT is likely a neoplastic process arising from synovial lining cells, in which tumor cells express the colony stimulating factor 1 (CSF1) gene. The postoperative recurrence rate of TSGCT is approximately 15%. The intrinsic characteristics of recurrence are not clear, and complete resection of the lesion is still the treatment mainstay. Moreover, TSGCT commonly grows out of a pseudocapsule. Therefore, to perform complete resection of TSGCT, surgery must be performed cautiously after appropriate preparation, by using anesthesia, a tourniquet, surgical loupe, and surgical microscopy. After accurate preoperative diagnosis, meticulous planning by surgeons is necessary. The lesion should be resected along with approximately 1-mm of healthy tissue at the adhesion site. In addition, because satellite lesions might be present near the tumor, careful dissection and observation of the color of surrounding tissue are important. International clinical trials of CSF1 receptor inhibitors for TSGCT treatment are ongoing.This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the complex relationship between tumor growth pattern and location, the high rate of postoperative recurrence, local invasiveness, use of nonsurgical therapy with molecularly targeted drugs, and best current treatments. This tumor has been referred to by various names, but is now most frequently referred to as TSGCT. TSGCT is classified as localized and diffuse, in accordance with its growth characteristics. Most TSGCTs of the fingers are localized. TSGCT is likely a neoplastic process arising from synovial lining cells, in which tumor cells express the colony stimulating factor 1 (CSF1) gene. The postoperative recurrence rate of TSGCT is approximately 15%. The intrinsic characteristics of recurrence are not clear, and complete resection of the lesion is still the treatment mainstay. Moreover, TSGCT commonly grows out of a pseudocapsule. Therefore, to perform complete resection of TSGCT, surgery must be performed cautiously after appropriate preparation, by using anesthesia, a tourniquet, surgical loupe, and surgical microscopy. After accurate preoperative diagnosis, meticulous planning by surgeons is necessary. The lesion should be resected along with approximately 1-mm of healthy tissue at the adhesion site. In addition, because satellite lesions might be present near the tumor, careful dissection and observation of the color of surrounding tissue are important. International clinical trials of CSF1 receptor inhibitors for TSGCT treatment are ongoing. This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names. the complex relationship between tumor growth pattern and location, the high rate of post-operative recurrence, local invasiveness, use of nonsurgical therapy with molecularly targeted drugs, and best current treatments. This tumor has been referred to by various names, but is now most frequently referred to as TSGCT. TSGCT is classified as localized and diffuse, in accordance with its growth characteristics. Most TSGCTs of the fingers are localized. TSGCT is likely a neoplastic process arising from synovial lining cells, in which tumor cells express the colony stimulating factor 1 (CSF1) gene. The postoperative recurrence rate of TSGCT is approximately 15%. The intrinsic characteristics of recurrence are not clear, and complete resection of the lesion is still the treatment mainstay. Moreover, TSGCT commonly grows out of a pseudocapsule. Therefore, to perform complete resection of TSGCT, surgery must be performed cautiously after appropriate preparation, by using anesthesia, a tourniquet, surgical loupe, and surgical microscopy. After accurate preoperative diagnosis, meticulous planning by surgeons is necessary. The lesion should be resected along with approximately 1-mm of healthy tissue at the adhesion site. In addition, because satellite lesions might be present near the tumor, careful dissection and observation of the color of surrounding tissue are important. International clinical trials of CSF1 receptor inhibitors for TSGCT treatment are ongoing. |
| Author | Kitagawa, Yasuyuki Takai, Shinro |
| Author_xml | – sequence: 1 fullname: Kitagawa, Yasuyuki organization: Department of Orthopaedic Surgery, Nippon Medical School – sequence: 1 fullname: Takai, Shinro organization: Department of Orthopaedic Surgery, Nippon Medical School |
| BookMark | eNqFUMFu1DAQjVCRaAufgJQjlywTO3FicUBoRbdAoQeWs-X1jqkjx15sh2r_HodUe1ghcZkZzbw3b-ZdFRfOOyyK1zWsatKRt4Mb4-rzt6_fVwQIiL6rGuifFZc1bbqKNsAv_tZt1bCOvSiuYhwAKG1bdlm8vz8kM0pbbgPKNKJLpfah3KLz8ej8b5NHGyNze402o6YxT70u0wOWt9LtXxbPtbQRXz3l6-LHzcft-ra6u998Wn-4q1QHkCrWMmhqDl0tUVNkVCm-2-3UvlckJ65Ip4kGzaFuFRCOVPXYNJRAwyhyTa8Ltuyd3EEeH6W14hDy4eEoahCzDWK2YQlPNohsQya-WYiH4H9NGJMYTVT5F-nQTxlLOevbrNJlaLtAVfAxBtT_lpidPpN4d8ZTJslkvEtBGvtf9mZhj7g3SlrvrHEoBj8Flx0V6rEe_OkrgL6DJicioO5zkU2lLWeUzJu-LJuGmORPPF0vQzLK4qI_q87h_I4TSj3IINDRP7Z5uL0 |
| CitedBy_id | crossref_primary_10_35366_107802 crossref_primary_10_1016_j_anplas_2025_02_002 crossref_primary_10_1016_j_asjsur_2023_05_168 crossref_primary_10_1016_j_ijscr_2022_107797 crossref_primary_10_1177_17531934231222401 crossref_primary_10_1007_s12262_022_03629_4 crossref_primary_10_7759_cureus_41532 crossref_primary_10_1016_j_anplas_2020_06_005 crossref_primary_10_1016_j_jorep_2024_100382 crossref_primary_10_52581_1814_1471_77_11 crossref_primary_10_1016_j_hansur_2022_04_005 crossref_primary_10_4274_BMB_galenos_2024_2024_03_031 |
| Cites_doi | 10.1016/j.bjps.2019.01.021 10.1142/S0218810499000046 10.1002/bjs.18003815102 10.1097/CCO.0b013e328354c16b 10.1186/s12891-019-2866-8 10.2214/ajr.183.2.1830337 10.1142/S0218810411005242 10.1007/s11552-011-9341-9 10.1016/S0266-7681(03)00222-5 10.1073/pnas.0507321103 10.3892/ol.2017.6011 10.7860/JCDR/2014/10553.5311 10.1080/02844310601159766 10.1016/S0266-7681(03)00225-0 10.1016/J.JHSB.2004.06.012 10.1093/annonc/mdn033 10.1016/S0266-7681(98)80084-3 10.1177/230949901101900218 10.1016/S0363-5023(84)80233-6 10.1272/jnms.79.267 10.1097/CCO.0b013e328347e1e3 10.1002/dc.22840 10.1054/jhsb.2000.0522 10.1016/j.jhsa.2009.12.004 10.1136/jcp.54.5.404 10.1016/j.otsr.2016.11.002 10.1016/j.jhsa.2009.06.012 10.1053/jhsu.1999.1298 10.1007/s00256-003-0689-y 10.1002/1097-0142(19860215)57:4<875::AID-CNCR2820570432>3.0.CO;2-Y 10.1016/j.otsr.2013.03.008 10.1097/SAP.0000000000001983 10.1016/S0363-5023(05)80148-0 10.1007/s00264-013-1994-2 10.1016/S1531-0914(03)00025-1 10.1002/(SICI)1096-9098(199806)68:2<100::AID-JSO5>3.0.CO;2-A 10.1097/00000637-198409000-00006 10.1016/j.jus.2011.02.001 10.1016/0165-4608(96)00064-7 10.11138/gchir/2013.34.5.149 10.1093/ajcp/102.1.87 10.1016/S0363-5023(98)80062-2 10.2106/00004623-196951010-00005 10.2106/00004623-198466010-00012 10.1016/j.ijrobp.2009.07.1747 10.1302/0301-620X.82B4.0820571 |
| ContentType | Journal Article |
| Copyright | 2020 by the Medical Association of Nippon Medical School |
| Copyright_xml | – notice: 2020 by the Medical Association of Nippon Medical School |
| CorporateAuthor | Nippon Medical School Department of Orthopaedic Surgery |
| CorporateAuthor_xml | – name: Nippon Medical School – name: Department of Orthopaedic Surgery |
| DBID | AAYXX CITATION 7X8 ADTOC UNPAY |
| DOI | 10.1272/jnms.JNMS.2020_87-408 |
| DatabaseName | CrossRef MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1347-3409 |
| EndPage | 190 |
| ExternalDocumentID | 10.1272/jnms.jnms.2020_87-408 10_1272_jnms_JNMS_2020_87_408 cw1jonms_2020_008704_002_0184_01903596328 article_jnms_87_4_87_JNMS_2020_87_408_article_char_en |
| GroupedDBID | 29L 2WC 53G 5GY ABDBF ACUHS AEGXH AENEX ALMA_UNASSIGNED_HOLDINGS CS3 DIK DU5 E3Z EBD EBS EJD EMOBN ESX F5P FRP GX1 JMI JSF JSH KQ8 MK0 MOJWN OVT RJT RNS RZJ SV3 TR2 TUS W2D XSB ~8M AAYXX CITATION 7X8 .55 ADTOC TKC UNPAY X7M |
| ID | FETCH-LOGICAL-c700t-6560419071aef3e63cc9bbbcd8c2bbc9c27f2f0f9015c029e3c8e44320463e9f3 |
| IEDL.DBID | UNPAY |
| ISSN | 1345-4676 1347-3409 |
| IngestDate | Tue Aug 19 21:49:12 EDT 2025 Fri Jul 11 16:34:58 EDT 2025 Tue Jul 01 01:18:02 EDT 2025 Thu Apr 24 23:09:05 EDT 2025 Thu Jul 10 16:12:51 EDT 2025 Wed Sep 03 06:29:12 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c700t-6560419071aef3e63cc9bbbcd8c2bbc9c27f2f0f9015c029e3c8e44320463e9f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.jstage.jst.go.jp/article/jnms/87/4/87_JNMS.2020_87-408/_pdf |
| PQID | 2396854637 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | unpaywall_primary_10_1272_jnms_jnms_2020_87_408 proquest_miscellaneous_2396854637 crossref_primary_10_1272_jnms_JNMS_2020_87_408 crossref_citationtrail_10_1272_jnms_JNMS_2020_87_408 medicalonline_journals_cw1jonms_2020_008704_002_0184_01903596328 jstage_primary_article_jnms_87_4_87_JNMS_2020_87_408_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020/08/15 |
| PublicationDateYYYYMMDD | 2020-08-15 |
| PublicationDate_xml | – month: 08 year: 2020 text: 2020/08/15 day: 15 |
| PublicationDecade | 2020 |
| PublicationTitle | Journal of Nippon Medical School |
| PublicationTitleAlternate | J Nippon Med Sch |
| PublicationYear | 2020 |
| Publisher | The Medical Association of Nippon Medical School |
| Publisher_xml | – name: The Medical Association of Nippon Medical School |
| References | 33. Lautenbach M, Kim S, Millrose M, Eisenschenk A. Nodular giant cell tumour of the tendon sheath of the hand: analysis of eighty-four cases: diagnostic decisions and outcome. Int Orthop. 2013;37:2211-5. 6. Ikeda K, Osamura N, Tomita K. Giant cell tumour in the tendon sheath of the hand: importance of the type of lesion. Scand J Plast Reconstr Surg Hand Surg. 2007;41:138-42. 8. Lancigu R, Rabarin F, Jeudy J, et al. Giant cell tumors of the tendon sheaths in the hand: review of 96 patients with an average follow-up of 12 years. Orthop Traumatol Surg Res. 2013;99:251-4. 27. Darwish FM, Haddad WH. Giant cell tumour of tendon sheath: experience with 52 cases. Singapore Med J. 2008;49:879-82. 37. Linney LS, Al-Hassani F, Pikturnaite J, et al. Tenosynovial giant cell tumours of the hand: a multicentre case-control study. J Plast Reconstr Aesthet Surg. 2019;72:918-23. 39. Shi J, Zheng J, Zhou X, et al. Risk factors associated with postoperative recurrence in patients with tenosynovial giant cell tumor of the hand: a retrospective cohort study. Ann Plast Surg. 2019;83:523-8. 14. Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Curr Opin Oncol. 2011;23:361-6. 32. Di Grazia S, Succi G, Fragetta F, Perrotta RE. Giant cell tumor of tendon sheath: study of 64 cases and review of literature. G Chir. 2013;34:149-52. 45. Rao AS, Vigorita VJ. Pigmented villonodular synovitis (giant-cell tumor of the tendon sheath and synovial membrane): a review of eighty-one cases. J Bone Joint Surg Am. 1984;66:76-94. 49. Middleton WD, Patel V, Teefey SA, Boyer MI. Giant cell tumors of the tendon sheath: analysis of sonographic findings. Am J Roentgenol. 2004;183:337-9. 12. Ohjimi Y, Iwasaki H, Ishiguro M, et al. Short arm of chromosome 1 aberration recurrently found in pigmented villonodular synovitis. Cancer Genet Cytogenet. 1996;90:80-5. 47. Rauh MA, Duquin TR, McGrath BE, Mindell ER. Spread of squamous cell carcinoma from the thumb to the small finger via the flexor tendon sheaths. J Hand Surg Am. 2009;34:1709-13. 52. Kitagawa Y, Ito H, Sawaizumi T, Matsubara M, Yokoyama M, Naito Z. Fine needle aspiration cytology for soft tissue tumours of the hand. J Hand Surg Br. 2003;28:582-5. 9. Glowacki KA. Giant cell tumors of tendon sheath. J Hand Surg Am. 2003;3:100-7. 20. Looi KP, Low CK, Yap YM. Pigmented villonodular synovitis of the hand in the Asian population. Hand Surg. 1999;4:81-5. 2. Somerhausen NSA, Cin PD. Giant cell tumor of tendon sheath. In: Fletcher DM, Unni KK, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. p. 110-1. 35. Koutserimpas C, Kastanis G, Ioannidis A, Filippou D, Balalis KJ. Giant cell tumors of the tendon sheath of the hand: an 11-year retrospective study. BUON. 2018;23:1546-51. 43. Rodrigues C, Desai S, Chinoy R. Giant cell tumor of the tendon sheath: a retrospective study of 28 cases. J Surg Oncol. 1998;68:100-3. 48. Bassetti E, Candreva R, Santucci E. Pigmented villonodular synovitis of the knee: A case report. J Ultrasound. 2011;14:167-9. 5. Al-Qattan MM. Giant cell tumours of tendon sheath: classification and recurrence rate. J Hand Surg Br. 2001;26:72-5. 10. Chaissaignac EDM. Cancer de la Gaines des Tendons[Cancer of the tendon sheath]. Gazette Hopitaux Militaires. 1852;47:185-6. French. 23. Grover R, Grobbelaar AO, Richman PI, Smith PJ. Measurement of invasive potential provides an accurate prognostic marker for giant cell tumour of tendon sheath. J Hand Surg Br. 1998;23:728-31. 46. Fyfe IS, Macfarlane A. Pigmented villonodular synovitis of the hand. The Hand. 1980;12:179-88. 53. Wakely PE, Frable WJ. Fine-needle aspiration biopsy cytology of giant-cell tumor of tendon sheath. Am J Clin Pathol. 1994;102:87-90. 24. Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg Am. 1999;24:1298-302. 26. Kitagawa Y, Ito H, Yokoyama M, Sawaizumi T, Maeda S. The effect of cellular proliferative activity on recurrence and local tumour extent of localized giant cell tumour of tendon sheath. J Hand Surg Br. 2004;29:604-7. 41. Lorea P, Van De Walle H, Kinnen L, Ledoux P, Moermans JP, Van Den Heule B. Giant cell tumours of the tendon sheath: lack of correlation between nm23-H1 expression and recurrence. J Hand Surg Br. 2004;29:67-70. 42. Savage RC, Mustafa EB. Giant cell tumor of tendon sheath (Localized nodular tenosynovitis). Ann Plast Surg. 1984;13:205-10. 19. Uriburu IJ, Levy VD. Intraosseous growth of giant cell tumors of the tendon sheath (localized nodular tenosynovitis) of the digits: report of 15 cases. J Hand Surg Am. 1998;23:732-6. 13. West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006;103:690-5. 21. Kitagawa Y, Tamai K, Tsunoda R, Sawaizumi T, Takai S. Bone changes associated with soft-tissue tumors of the hand. J Nippon Med Sch. 2012;79:267-73. 15. Temple HT. Pigmented villonodular synovitis therapy with MSCF-1 inhibitors. Curr Opin Oncol. 2012;24:404-8. 50. Wang C, Song RR, Kuang PD, Wang LH, Zhang MM. Giant cell tumor of the tendon sheath: Magnetic resonance imaging findings in 38 patients. Oncol Lett. 2017;13:4459-62. 55. Fletcher AG Jr, Horn RC Jr. Giant cell tumors of tendon sheath origin: a consideration of bone involvement and report of two cases with extensive bone destruction. Ann Surg. 1950;81:374-85. 7. Fotiadis E, Papadopoulos A, Svarnas T, Akritopoulos P, Sachinis NP, Chalidis BE. Giant cell tumour of tendon sheath of the digits. A systematic review. Hand (NY). 2011;6:244-9. 11. Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis and tenosynovitis. Archives of Pathology. 1941;31:731-65. 3. Jones FE, Soule EH, Coventry MB. Fibrous xanthoma of synovium (giant-cell tumor of tendon sheath, pigmented nodular synovitis). J Bone Joint Surg Am. 1969;51:76-86. 4. Williams J, Hodari A, Janevski P, Siddiqui A. Recurrence of giant cell tumors in the hand: a prospective study. J Hand Surg Am. 2010;35:451-6. 54. Booth KC, Campbell GC, Chase DR. Giant cell tumors of the tendon sheath with intraosseous invasion: a case report. J Hand Surg Am. 1995;20:1000-2. 51. Ho CY, Maleki Z. Giant cell tumor of tendon sheath: cytomorphologic and radiologic findings in 41 patients. Diagn Cytopathol. 2012;40:E94-8. 22. Moore JR, Weiland AJ, Curtis RM. Localized nodular tenosynovitis: experience with 115 cases. J Hand Surg Am. 1984;9:412-7. 28. Suresh SS, Zaki H. Giant cell tumor of tendon sheath: case series and review of literature. J Hand Microsurg. 2010;2:67-71. 57. Blay JY, E Sayadi H, Thiesse P, Garret J, Ray-Coquard I. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol. 2008;19:821-2. 17. Wright CJ. Benign giant-cell synovioma: an investigation of 85 cases. Br J Surg. 1951;38:257-71. 18. Phalen GS, McCormack LJ, Gazele WJ. Giant-cell tumor of tendon sheath (benign synovioma) in the hand: evaluation of 56 cases. Clin Orthop. 1959;15:140-51. 29. Garg B, Kotwal PP. Giant cell tumour of the tendon sheath of the hand. J Orthop Surg (Hong Kong). 2011;19:218-20. 34. Bedir R, Balik MS, Sehitoglu I, Güçer H, Yurdakul C. Giant cell tumour of the tendon sheath: analysis of 35 cases and their Ki-67 proliferation indexes. J Clin Diagn Res. 2014;8:FC12-5. 16. Kitagawa Y, Ito H, Amano Y, Sawaizumi T, Takeuchi T. MR imaging for preoperative diagnosis and assessment of local tumor extent on localized giant cell tumor of tendon sheath. Skeletal Radiol. 2003;32:633-8. 1. Ushijima M, Hashimoto H, Tsuneyoshi M, Enjoji M. Giant cell tumor the tendon sheath (nodular tenosynovitis). Cancer. 1986;57:875-84. 31. Adams EL, Yoder EM, Kasdan ML. Giant cell tumor of the tendon sheath: experience with 65 cases. Eplasty. 2012;12:e50. 25. Kotwal PP, Gupta V, Malhotra R. Giant-cell tumour of the tendon sheath. Is radiotherapy indicated to prevent recurrence after surgery? J Bone Joint Surg Br. 2000;82:571-3. 40. Monaghan H, Salter DM, Al-Nafussi A. Giant cell tumour of tendon sheath (localized nodular tenosynovitis): clinicopathological features of 71 cases. J Clin Pathol. 2001;54:404-7. 56. Heyd R, Micke O, Berger B, Eich HT, Ackermann H, Seegenschmiedt MH. Radiation therapy for treatment of pigmented villonodular synovitis: results of a national patterns of care study. Int J Radiat Oncol Biol Phys. 2010;78:199-204. 44. Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthop Traumatol Surg Res. 2017;103:S91-7. 38. Ozben H, Coskun T. Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases. BMC Musculoskelet Disord. 2019;20:457. Available from: dio: 10.1186/s12891-019-2866-8 30. Jalgaonkar A, Dhinsa B, Cottam H, Mani G. Giant cell tumours of tendon sheath of hand: causes and strategies to prevent recurrence. Hand Surg. 2011;16:149-54. 36. Galbiatti JA, Milhomens GRDS, Silva LFHFE, Santiago DDS, Silva Neto JCD, Belluci SOB. Retrospective study of the results of surgical treatment of 31 giant cell tumors of the tendon sheath in the hand. Rev Bras Ortop (Sao Paulo). 2019;54:26-32. 44 45 46 47 48 49 50 51 52 53 10 54 55 12 56 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 22 23 24 25 26 27 28 29 HL Jaffe (11) 1941; 31 30 31 32 33 34 35 36 37 38 39 40 41 42 43 |
| References_xml | – reference: 28. Suresh SS, Zaki H. Giant cell tumor of tendon sheath: case series and review of literature. J Hand Microsurg. 2010;2:67-71. – reference: 39. Shi J, Zheng J, Zhou X, et al. Risk factors associated with postoperative recurrence in patients with tenosynovial giant cell tumor of the hand: a retrospective cohort study. Ann Plast Surg. 2019;83:523-8. – reference: 7. Fotiadis E, Papadopoulos A, Svarnas T, Akritopoulos P, Sachinis NP, Chalidis BE. Giant cell tumour of tendon sheath of the digits. A systematic review. Hand (NY). 2011;6:244-9. – reference: 22. Moore JR, Weiland AJ, Curtis RM. Localized nodular tenosynovitis: experience with 115 cases. J Hand Surg Am. 1984;9:412-7. – reference: 13. West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006;103:690-5. – reference: 52. Kitagawa Y, Ito H, Sawaizumi T, Matsubara M, Yokoyama M, Naito Z. Fine needle aspiration cytology for soft tissue tumours of the hand. J Hand Surg Br. 2003;28:582-5. – reference: 38. Ozben H, Coskun T. Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases. BMC Musculoskelet Disord. 2019;20:457. Available from: dio: 10.1186/s12891-019-2866-8 – reference: 24. Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg Am. 1999;24:1298-302. – reference: 27. Darwish FM, Haddad WH. Giant cell tumour of tendon sheath: experience with 52 cases. Singapore Med J. 2008;49:879-82. – reference: 14. Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Curr Opin Oncol. 2011;23:361-6. – reference: 34. Bedir R, Balik MS, Sehitoglu I, Güçer H, Yurdakul C. Giant cell tumour of the tendon sheath: analysis of 35 cases and their Ki-67 proliferation indexes. J Clin Diagn Res. 2014;8:FC12-5. – reference: 45. Rao AS, Vigorita VJ. Pigmented villonodular synovitis (giant-cell tumor of the tendon sheath and synovial membrane): a review of eighty-one cases. J Bone Joint Surg Am. 1984;66:76-94. – reference: 10. Chaissaignac EDM. Cancer de la Gaines des Tendons[Cancer of the tendon sheath]. Gazette Hopitaux Militaires. 1852;47:185-6. French. – reference: 23. Grover R, Grobbelaar AO, Richman PI, Smith PJ. Measurement of invasive potential provides an accurate prognostic marker for giant cell tumour of tendon sheath. J Hand Surg Br. 1998;23:728-31. – reference: 4. Williams J, Hodari A, Janevski P, Siddiqui A. Recurrence of giant cell tumors in the hand: a prospective study. J Hand Surg Am. 2010;35:451-6. – reference: 31. Adams EL, Yoder EM, Kasdan ML. Giant cell tumor of the tendon sheath: experience with 65 cases. Eplasty. 2012;12:e50. – reference: 8. Lancigu R, Rabarin F, Jeudy J, et al. Giant cell tumors of the tendon sheaths in the hand: review of 96 patients with an average follow-up of 12 years. Orthop Traumatol Surg Res. 2013;99:251-4. – reference: 15. Temple HT. Pigmented villonodular synovitis therapy with MSCF-1 inhibitors. Curr Opin Oncol. 2012;24:404-8. – reference: 42. Savage RC, Mustafa EB. Giant cell tumor of tendon sheath (Localized nodular tenosynovitis). Ann Plast Surg. 1984;13:205-10. – reference: 56. Heyd R, Micke O, Berger B, Eich HT, Ackermann H, Seegenschmiedt MH. Radiation therapy for treatment of pigmented villonodular synovitis: results of a national patterns of care study. Int J Radiat Oncol Biol Phys. 2010;78:199-204. – reference: 12. Ohjimi Y, Iwasaki H, Ishiguro M, et al. Short arm of chromosome 1 aberration recurrently found in pigmented villonodular synovitis. Cancer Genet Cytogenet. 1996;90:80-5. – reference: 46. Fyfe IS, Macfarlane A. Pigmented villonodular synovitis of the hand. The Hand. 1980;12:179-88. – reference: 21. Kitagawa Y, Tamai K, Tsunoda R, Sawaizumi T, Takai S. Bone changes associated with soft-tissue tumors of the hand. J Nippon Med Sch. 2012;79:267-73. – reference: 57. Blay JY, E Sayadi H, Thiesse P, Garret J, Ray-Coquard I. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol. 2008;19:821-2. – reference: 19. Uriburu IJ, Levy VD. Intraosseous growth of giant cell tumors of the tendon sheath (localized nodular tenosynovitis) of the digits: report of 15 cases. J Hand Surg Am. 1998;23:732-6. – reference: 41. Lorea P, Van De Walle H, Kinnen L, Ledoux P, Moermans JP, Van Den Heule B. Giant cell tumours of the tendon sheath: lack of correlation between nm23-H1 expression and recurrence. J Hand Surg Br. 2004;29:67-70. – reference: 2. Somerhausen NSA, Cin PD. Giant cell tumor of tendon sheath. In: Fletcher DM, Unni KK, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. p. 110-1. – reference: 1. Ushijima M, Hashimoto H, Tsuneyoshi M, Enjoji M. Giant cell tumor the tendon sheath (nodular tenosynovitis). Cancer. 1986;57:875-84. – reference: 30. Jalgaonkar A, Dhinsa B, Cottam H, Mani G. Giant cell tumours of tendon sheath of hand: causes and strategies to prevent recurrence. Hand Surg. 2011;16:149-54. – reference: 50. Wang C, Song RR, Kuang PD, Wang LH, Zhang MM. Giant cell tumor of the tendon sheath: Magnetic resonance imaging findings in 38 patients. Oncol Lett. 2017;13:4459-62. – reference: 25. Kotwal PP, Gupta V, Malhotra R. Giant-cell tumour of the tendon sheath. Is radiotherapy indicated to prevent recurrence after surgery? J Bone Joint Surg Br. 2000;82:571-3. – reference: 44. Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthop Traumatol Surg Res. 2017;103:S91-7. – reference: 11. Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis and tenosynovitis. Archives of Pathology. 1941;31:731-65. – reference: 49. Middleton WD, Patel V, Teefey SA, Boyer MI. Giant cell tumors of the tendon sheath: analysis of sonographic findings. Am J Roentgenol. 2004;183:337-9. – reference: 3. Jones FE, Soule EH, Coventry MB. Fibrous xanthoma of synovium (giant-cell tumor of tendon sheath, pigmented nodular synovitis). J Bone Joint Surg Am. 1969;51:76-86. – reference: 33. Lautenbach M, Kim S, Millrose M, Eisenschenk A. Nodular giant cell tumour of the tendon sheath of the hand: analysis of eighty-four cases: diagnostic decisions and outcome. Int Orthop. 2013;37:2211-5. – reference: 20. Looi KP, Low CK, Yap YM. Pigmented villonodular synovitis of the hand in the Asian population. Hand Surg. 1999;4:81-5. – reference: 26. Kitagawa Y, Ito H, Yokoyama M, Sawaizumi T, Maeda S. The effect of cellular proliferative activity on recurrence and local tumour extent of localized giant cell tumour of tendon sheath. J Hand Surg Br. 2004;29:604-7. – reference: 48. Bassetti E, Candreva R, Santucci E. Pigmented villonodular synovitis of the knee: A case report. J Ultrasound. 2011;14:167-9. – reference: 36. Galbiatti JA, Milhomens GRDS, Silva LFHFE, Santiago DDS, Silva Neto JCD, Belluci SOB. Retrospective study of the results of surgical treatment of 31 giant cell tumors of the tendon sheath in the hand. Rev Bras Ortop (Sao Paulo). 2019;54:26-32. – reference: 29. Garg B, Kotwal PP. Giant cell tumour of the tendon sheath of the hand. J Orthop Surg (Hong Kong). 2011;19:218-20. – reference: 55. Fletcher AG Jr, Horn RC Jr. Giant cell tumors of tendon sheath origin: a consideration of bone involvement and report of two cases with extensive bone destruction. Ann Surg. 1950;81:374-85. – reference: 40. Monaghan H, Salter DM, Al-Nafussi A. Giant cell tumour of tendon sheath (localized nodular tenosynovitis): clinicopathological features of 71 cases. J Clin Pathol. 2001;54:404-7. – reference: 53. Wakely PE, Frable WJ. Fine-needle aspiration biopsy cytology of giant-cell tumor of tendon sheath. Am J Clin Pathol. 1994;102:87-90. – reference: 16. Kitagawa Y, Ito H, Amano Y, Sawaizumi T, Takeuchi T. MR imaging for preoperative diagnosis and assessment of local tumor extent on localized giant cell tumor of tendon sheath. Skeletal Radiol. 2003;32:633-8. – reference: 51. Ho CY, Maleki Z. Giant cell tumor of tendon sheath: cytomorphologic and radiologic findings in 41 patients. Diagn Cytopathol. 2012;40:E94-8. – reference: 32. Di Grazia S, Succi G, Fragetta F, Perrotta RE. Giant cell tumor of tendon sheath: study of 64 cases and review of literature. G Chir. 2013;34:149-52. – reference: 54. Booth KC, Campbell GC, Chase DR. Giant cell tumors of the tendon sheath with intraosseous invasion: a case report. J Hand Surg Am. 1995;20:1000-2. – reference: 47. Rauh MA, Duquin TR, McGrath BE, Mindell ER. Spread of squamous cell carcinoma from the thumb to the small finger via the flexor tendon sheaths. J Hand Surg Am. 2009;34:1709-13. – reference: 9. Glowacki KA. Giant cell tumors of tendon sheath. J Hand Surg Am. 2003;3:100-7. – reference: 18. Phalen GS, McCormack LJ, Gazele WJ. Giant-cell tumor of tendon sheath (benign synovioma) in the hand: evaluation of 56 cases. Clin Orthop. 1959;15:140-51. – reference: 6. Ikeda K, Osamura N, Tomita K. Giant cell tumour in the tendon sheath of the hand: importance of the type of lesion. Scand J Plast Reconstr Surg Hand Surg. 2007;41:138-42. – reference: 5. Al-Qattan MM. Giant cell tumours of tendon sheath: classification and recurrence rate. J Hand Surg Br. 2001;26:72-5. – reference: 35. Koutserimpas C, Kastanis G, Ioannidis A, Filippou D, Balalis KJ. Giant cell tumors of the tendon sheath of the hand: an 11-year retrospective study. BUON. 2018;23:1546-51. – reference: 37. Linney LS, Al-Hassani F, Pikturnaite J, et al. Tenosynovial giant cell tumours of the hand: a multicentre case-control study. J Plast Reconstr Aesthet Surg. 2019;72:918-23. – reference: 43. Rodrigues C, Desai S, Chinoy R. Giant cell tumor of the tendon sheath: a retrospective study of 28 cases. J Surg Oncol. 1998;68:100-3. – reference: 17. Wright CJ. Benign giant-cell synovioma: an investigation of 85 cases. Br J Surg. 1951;38:257-71. – ident: 2 – ident: 36 doi: 10.1016/j.bjps.2019.01.021 – ident: 20 doi: 10.1142/S0218810499000046 – ident: 35 – ident: 17 doi: 10.1002/bjs.18003815102 – ident: 15 doi: 10.1097/CCO.0b013e328354c16b – ident: 37 doi: 10.1186/s12891-019-2866-8 – ident: 48 doi: 10.2214/ajr.183.2.1830337 – ident: 30 doi: 10.1142/S0218810411005242 – ident: 7 doi: 10.1007/s11552-011-9341-9 – ident: 40 doi: 10.1016/S0266-7681(03)00222-5 – ident: 13 doi: 10.1073/pnas.0507321103 – ident: 45 – ident: 49 doi: 10.3892/ol.2017.6011 – ident: 33 doi: 10.7860/JCDR/2014/10553.5311 – ident: 6 doi: 10.1080/02844310601159766 – ident: 51 doi: 10.1016/S0266-7681(03)00225-0 – ident: 26 doi: 10.1016/J.JHSB.2004.06.012 – ident: 56 doi: 10.1093/annonc/mdn033 – ident: 23 doi: 10.1016/S0266-7681(98)80084-3 – ident: 29 doi: 10.1177/230949901101900218 – ident: 34 – ident: 22 doi: 10.1016/S0363-5023(84)80233-6 – ident: 54 – ident: 21 doi: 10.1272/jnms.79.267 – ident: 14 doi: 10.1097/CCO.0b013e328347e1e3 – ident: 50 doi: 10.1002/dc.22840 – ident: 5 doi: 10.1054/jhsb.2000.0522 – ident: 4 doi: 10.1016/j.jhsa.2009.12.004 – ident: 27 – ident: 18 – ident: 39 doi: 10.1136/jcp.54.5.404 – ident: 43 doi: 10.1016/j.otsr.2016.11.002 – ident: 46 doi: 10.1016/j.jhsa.2009.06.012 – ident: 10 – ident: 24 doi: 10.1053/jhsu.1999.1298 – ident: 16 doi: 10.1007/s00256-003-0689-y – ident: 28 – ident: 1 doi: 10.1002/1097-0142(19860215)57:4<875::AID-CNCR2820570432>3.0.CO;2-Y – ident: 8 doi: 10.1016/j.otsr.2013.03.008 – ident: 38 doi: 10.1097/SAP.0000000000001983 – ident: 53 doi: 10.1016/S0363-5023(05)80148-0 – ident: 32 doi: 10.1007/s00264-013-1994-2 – ident: 9 doi: 10.1016/S1531-0914(03)00025-1 – ident: 42 doi: 10.1002/(SICI)1096-9098(199806)68:2<100::AID-JSO5>3.0.CO;2-A – ident: 41 doi: 10.1097/00000637-198409000-00006 – ident: 47 doi: 10.1016/j.jus.2011.02.001 – volume: 31 start-page: 731 issn: 0003-9985 year: 1941 ident: 11 publication-title: Archives of Pathology & Laboratory Medicine – ident: 12 doi: 10.1016/0165-4608(96)00064-7 – ident: 31 doi: 10.11138/gchir/2013.34.5.149 – ident: 52 doi: 10.1093/ajcp/102.1.87 – ident: 19 doi: 10.1016/S0363-5023(98)80062-2 – ident: 3 doi: 10.2106/00004623-196951010-00005 – ident: 44 doi: 10.2106/00004623-198466010-00012 – ident: 55 doi: 10.1016/j.ijrobp.2009.07.1747 – ident: 25 doi: 10.1302/0301-620X.82B4.0820571 |
| SSID | ssj0033556 ssib003113106 ssib000959778 ssib015835743 |
| Score | 2.2671082 |
| SecondaryResourceType | review_article |
| Snippet | This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names, the complex relationship between tumor growth... This review examines the following aspects of tenosynovial giant cell tumors (TSGCTs): the use of multiple names. the complex relationship between tumor growth... |
| SourceID | unpaywall proquest crossref medicalonline jstage |
| SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 184 |
| SubjectTerms | finger giant cell tumor of the tendon sheath hand recurrence tenosynovial giant cell tumor |
| Title | Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand |
| URI | https://www.jstage.jst.go.jp/article/jnms/87/4/87_JNMS.2020_87-408/_article/-char/en http://mol.medicalonline.jp/library/journal/download?GoodsID=cw1jonms/2020/008704/002&name=0184-0190e https://www.proquest.com/docview/2396854637 https://www.jstage.jst.go.jp/article/jnms/87/4/87_JNMS.2020_87-408/_pdf |
| UnpaywallVersion | publishedVersion |
| Volume | 87 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Nippon Medical School, 2020/08/15, Vol.87(4), pp.184-190 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1347-3409 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0033556 issn: 1347-3409 databaseCode: KQ8 dateStart: 19990101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1347-3409 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0033556 issn: 1347-3409 databaseCode: ABDBF dateStart: 20070401 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1347-3409 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0033556 issn: 1347-3409 databaseCode: DIK dateStart: 19230101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1347-3409 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0033556 issn: 1347-3409 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ra9swED_adOzB2HssexQP9tUvSbbjT1vp1oRCssESyD4JW5E6vMQOa7LS_fW7s2WTjMEY7IuF8Z0snU7y7yzdHcAbHRmdccFdnYSRKyKlKZE7c_OUJXkaiigz9GtgPIlHM3E-j-YHMGx9YehYZYG46EJT4V1UXrH2rRD9olxd-oPEF3iR55PxZ7TvWCBxmohg4Mv1whzCURwhKO_B0Wzy6eRLbW4JbERcp5kjv0mXo0ljfXlYwupKvfqyU9neV-pG06A7cHfVbJ40QSz2MOmtbbnOrq-y5XLn83R2H762HWtOpXzztpvcUz9_i_n4H3r-AO5ZCOucNEwP4UCXj-Dm2G7SP4a3H3EZWiHFtD3E7iAydqYUlvy6rH6gxjtD1MqNc6qXSLVd4dPKOAhFnVFWLp7A7OzD9HTk2jwNrkqCYONS_B6BwCIJM224jrlSaZ7nFHWAYZEqlhhmAkPQQwUs1VwNtBCcUbQynRr-FHplVepn4CilIqG1iRFVCLVIBzxnRikTRDhUoVZ9EO24SGWDmFMujaUkYwZpJEmqlpC0EpIooT54Hdu6ieLxN4b3zVh05HYkGnIiknYkdtk6KnKZw3WnD-_2VEbaBeJSqquwqKiqmpsCAwYCCyYDNLklOfhz1GPOsCWvWy2TOPNpOycrdbVFTp7GA8pmkPTB79Tvz_0rulc1DX3-zxwv4Dbd0e_0MHoJvc33rX6FeGyTH8PhcB4e2xn3C1FwMZA |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ra9swED-6dOzB2LNj2QsP9tUvSbbjT1vp1oZCssES6D4JW5E60sQOq73S_fW7s2WTjMEY7IuF8Z0snU7y7yzdHcBbHRmdccFdnYSRKyKlKZE7c_OUJXkaiigz9GtgMo3Hc3F6Fp3twUnnC0PHKpeIi841Fd556S03vhWivyzWl_4o8QVe5Ol08gXtOxZInCYiGPlyszA3YD-OEJQPYH8-_Xz4tTG3BDYibtLMkd-ky9Gksb48LGFNpV5z2aps5yt1s23QXbi3bjdP2iAWO5j0dl1ssuurbLXa-jwdP4BvXcfaUykXXl3lnvr5W8zH_9Dzh3DfQljnsGV6BHu6eAy3JnaT_gm8-4TL0BopZt0hdgeRsTOjsOTXRfkDNd45Qa2snCO9Qqp6jU9L4yAUdcZZsTiA-fHH2dHYtXkaXJUEQeVS_B6BwCIJM224jrlSaZ7nFHWAYZEqlhhmAkPQQwUs1VyNtBCcUbQynRr-FAZFWehn4CilIqG1iRFVCLVIRzxnRikTRDhUoVZDEN24SGWDmFMujZUkYwZpJEmqkZC0EpIooSF4PdumjeLxN4YP7Vj05HYkWnIiknYkttl6KnKZw3VnCO93VEbaBeJSqqtwWVJVDTcFBgwEFkwGaHJLcvDnqMecYUvedFomcebTdk5W6LJGTp7GI8pmkAzB79Xvz_1b9q9qG_r8nzlewB26o9_pYfQSBtX3Wr9CPFblr-1c-wUtyTCf |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimal+Treatment+for+Tenosynovial+Giant+Cell+Tumor+of+the+Hand&rft.jtitle=Journal+of+Nippon+Medical+School&rft.au=Yasuyuki+Kitagawa&rft.au=Shinro+Takai&rft.date=2020-08-15&rft.pub=The+Medical+Association+of+Nippon+Medical+School&rft.issn=1345-4676&rft.volume=87&rft.issue=4&rft.spage=184&rft.epage=190&rft_id=info:doi/10.1272%2Fjnms.JNMS.2020_87-408&rft.externalDocID=cw1jonms_2020_008704_002_0184_01903596328 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1345-4676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1345-4676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1345-4676&client=summon |